drug
pramipexole dihydrochloride
Marketedupdated 4mo agoby Shasun USA Inc
Approvedcommunity read0 votes
indications
investigational
Parkinson's Disease
all catalysts(0)
nothing on the calendar yet
Trials studying pramipexole dihydrochloride
- phase1Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects
- phase3Phase III Long-Term Extension Study With Dexpramipexole
- phase3A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
- phase3A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
- phase3A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
- phase2A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
Patent cliff
source: FDA Orange Bookfirst barrier falls
Apr 26, 2028
~1.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (14)
- Sep 8, 2029formulationUS 86795333.0y
- Sep 8, 2029formulationUS 86795333.0y
- Sep 8, 2029formulationUS 86795333.0y
- Sep 8, 2029formulationUS 86795333.0y
- Sep 8, 2029formulationUS 86795333.0y
- Sep 8, 2029formulationUS 86795333.0y
- Sep 8, 2029formulationUS 86795333.0y
- Apr 26, 2028formulationUS 76957341.7y
- Apr 26, 2028formulationUS 76957341.7y
- Apr 26, 2028formulationUS 76957341.7y
- Apr 26, 2028formulationUS 76957341.7y
- Apr 26, 2028formulationUS 76957341.7y
- Apr 26, 2028formulationUS 76957341.7y
- Apr 26, 2028formulationUS 76957341.7y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that